1. 1999 Worl Healt Organization International Society of Hypertension guidelines for the management of hypertension. 1999 WHO ISH Guidelines.

2. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 39) UK prospective diabetes study group. BMJ 1998; 317: 713-20.

3. Garg R, Yusuf S, for the collaborative group on ACE inhibitors trials. Overview of randomized trials of angiotensine-converting enzime inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-6

4. Hanson L, Lindholm LH, Nisknan K et al. Effect of angiotensin-convertin-enzime inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999, 353, 611-16.

5. Hanson L, Zanchetti A, Carruters SG et al. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension : principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351:1755-62

6. Lewis EJ, Hunsincker LG, Bain RP, Rohde RD, for the collaborative study group on ACE inhibitors trials. The effect of angiotensine-converting enzime inhibition on diabetic nepropathy. The collaborative study group. N Eng J Med 1993; 329: 1456-62.

7. Moser M, Ross H. The treatment of hypertension in diabetic patients Diabetes care 1993; 16:542-7.

8. Moser M. National recommendations for the pharmacological treatment of hypertension: Shoul they be revised. Arch Int Med 1999; 159: 1403-7.

9. Pickering TG. Recomendations for the use of ambulatoory blood pressure monitoring. AJH 1995; 9:1-11.

10. Report of the Joint National Committe on Prevention, detecction , Evaluation and treatment of high blood pressure (JNV VI). Arc Int Med. 1997; 157:2413-2446.

11. Ruilope LM, Garcia Robles R. How far should blood pressure be reduced in diabetic hypertensive patients? J Hypertens 1997 15(supl2):S63-5.

12. Serrano Ríos M. DIAPASON: Estudio nacional sobre las características de la hipertensión arterial en el paciente diabético. Editorial Meditor SL. Madrid 1993.

13. SHEP cooperative research group. Prevention of stroke by antihipertenive drug treatment in older persons with isolated systolic hypertension. Final result of the systolic hypertension in the elderly program (SHEP). JAMA 1991, 265:3255-64.

14. Staessen JA, Fargard R, Thoijs, Let al. For the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised doubled blind comparison of placebo and active treatment for older patients with isolated systolic Hypertension. Lancet 1997; 350: 757-64.

15. Tovar JL. Automedición de la presión arterial. Presión arterial. Revista de hipertensión para atención primaria. 1999. Vol 1-6:10-36.

16. UK prospective diabetes study group Tiht blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 38). BMJ 1998; 317: 703-713.